Programming immunogenicity of dengue EDIII vaccine antigens using engineered outer membrane vesicles (OMVs)
Dengue is a mosquito-borne viral infection and is more prevalent in the world with no therapeutics and suboptimal vaccine (Dengvaxia) performance against all four serotypes of the dengue virus. Hence, there is an urgent requirement for a non-infectious and non-replicative vaccine candidate that can...
Saved in:
| Main Authors: | Srinivas Duvvada, Farhan Ahmed, Rafiq Ahmad Khan, Shaikh Matin Rahim, Saima Naz, Aradhana Mariam Philips, David Putnam, Avery August, Nooruddin Khan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Vaccine: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136225000737 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a Recombinant Outer Membrane Vesicles (OMVs)‐Based Vaccine Against Helicobacter pylori Infection in Mice
by: Qiong Liu, et al.
Published: (2025-05-01) -
Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c
by: Ava Behrouzi, et al.
Published: (2016-12-01) -
Bacterial Outer Membrane Vesicles: From Physics to Clinical
by: Jun Zhou, et al.
Published: (2025-06-01) -
Assessment of periodontitis vaccine using three different bacterial outer membrane vesicles in canine model
by: Ryoma Nakao, et al.
Published: (2025-04-01) -
Corporate Sustainability and Organizational Change. Case of OMV Petrom
by: Catalina Soriana Sitnikov, et al.
Published: (2012-06-01)